ReviewBMJ (Clinical research ed.)1999

Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold.

R Foy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.